KRTAP19-2
gene geneOn this page
Also known as KAP19.2
Summary
KRTAP19-2 (keratin associated protein 19-2, HGNC:18937) is a protein-coding gene on chromosome 21q22.11, encoding Keratin-associated protein 19-2 (Q3LHN2). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
Predicted to be located in cytosol.
Source: NCBI Gene 337969 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 9 total
- MANE Select transcript:
NM_181608
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18937 |
| Approved symbol | KRTAP19-2 |
| Name | keratin associated protein 19-2 |
| Location | 21q22.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP19.2 |
| Ensembl gene | ENSG00000186965 |
| Ensembl biotype | protein_coding |
| Entrez | 337969 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000334055
RefSeq mRNA: 1 — MANE Select: NM_181608
NM_181608
CCDS: CCDS13595
Canonical transcript exons
ENST00000334055 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001338566 | 30487043 | 30487436 |
Expression profiles
Bgee: expression breadth tissue_specific, 10 present calls, max score 44.79.
Top tissues by expression
114 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 44.79 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| liver | UBERON:0002107 | 28.04 | gold quality |
| urinary bladder | UBERON:0001255 | 27.60 | silver quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| blood | UBERON:0000178 | 26.04 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| monocyte | CL:0000576 | 25.59 | silver quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| pancreas | UBERON:0001264 | 24.10 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
| frontal cortex | UBERON:0001870 | 23.85 | gold quality |
| kidney | UBERON:0002113 | 23.19 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.82 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Keratin-associated protein 19-2 — Q3LHN2 (reviewed: Q3LHN2)
All UniProt accessions (1): Q3LHN2
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Similarity. Belongs to the KRTAP type 19 family.
RefSeq proteins (1): NP_853639* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR021743 | KRTAP_type8/19/20/21/22 | Family |
Pfam: PF11759
UniProt features (3 total): sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3LHN2-F1 | 43.39 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 9 (showing top):
chr21q22, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, NOTCH3_TARGET_GENES, CTTTGA_LEF1_Q2, YCATTAA_UNKNOWN
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
114 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP19-2 | KRTAP13-2 | Q52LG2 | 590 |
| KRTAP19-2 | KRTAP19-3 | Q7Z4W3 | 583 |
| KRTAP19-2 | KRTAP13-1 | Q8IUC0 | 578 |
| KRTAP19-2 | KRTAP20-2 | Q3LI61 | 507 |
| KRTAP19-2 | C21orf58 | P58505 | 477 |
| KRTAP19-2 | KRTAP9-2 | Q9BYQ4 | 476 |
| KRTAP19-2 | ZNF708 | P17019 | 447 |
| KRTAP19-2 | ZNF492 | Q9P255 | 447 |
| KRTAP19-2 | KRT2 | P35908 | 395 |
| KRTAP19-2 | SCAF4 | O95104 | 325 |
| KRTAP19-2 | ZNF154 | Q13106 | 322 |
| KRTAP19-2 | KRT75 | O95678 | 260 |
| KRTAP19-2 | SPRR1A | P35321 | 259 |
| KRTAP19-2 | KRT10 | P13645 | 253 |
| KRTAP19-2 | SLC31A2 | O15432 | 248 |
IntAct
151 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MKRN3 | KRTAP19-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEKT4 | KRTAP19-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RHBG | KRTAP19-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TENT5D | KRTAP19-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CREB5 | KRTAP19-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PCSK5 | KRTAP19-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP4-12 | KRTAP19-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FOXH1 | KRTAP19-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP19-2 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| FBLN1 | KRTAP19-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPAG8 | KRTAP19-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CHRD | KRTAP19-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TFAP2D | KRTAP19-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP19-2 | ATN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SNRPC | KRTAP19-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZIC1 | KRTAP19-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MEIS2 | KRTAP19-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP19-2 | KRTAP3-3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP19-2 | OLIG3 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (47): KRTAP19-2 (Two-hybrid), KRTAP19-2 (Two-hybrid), KRTAP19-2 (Two-hybrid), KRTAP19-2 (Two-hybrid), KRTAP19-2 (Two-hybrid), KRTAP19-2 (Two-hybrid), KRTAP19-2 (Two-hybrid), KRTAP19-2 (Two-hybrid), KRTAP19-2 (Two-hybrid), KRTAP19-2 (Two-hybrid), KRTAP19-2 (Two-hybrid), KRTAP19-2 (Two-hybrid), KRTAP19-2 (Two-hybrid), KRTAP19-2 (Two-hybrid), KRTAP19-2 (Two-hybrid)
ESM2 similar proteins: H2A0M6, O08632, O08633, O08640, P02448, P04459, P05685, P08826, P25692, P82170, P83358, Q02957, Q02958, Q28580, Q3LHN2, Q3LI54, Q3LI58, Q3LI59, Q3LI60, Q3LI61, Q3LI63, Q3LI64, Q3LI66, Q3LI67, Q3LI68, Q3LI70, Q3LI72, Q3LI73, Q3LI77, Q3MIV0, Q3SYF9, Q4W7G7, Q4W7G8, Q4W7G9, Q4W7H0, Q4W7H1, Q6F4C6, Q6R645, Q7Z4W3, Q8C1I6
Diamond homologs: Q3LHN2, Q3LI72, O08632, Q3LI60, Q3LI70, Q3LI73, Q3SYF9, Q7Z4W3, Q8IUB9, Q925H2, Q925H7, Q925I0, Q99NG9
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 44 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 6 | 11.5× | 1e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
9 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 6 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
138 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:30487407:A:AC | donor_gain | 0.8900 |
| 21:30487408:C:CC | donor_gain | 0.8900 |
| 21:30487274:T:C | donor_gain | 0.8500 |
| 21:30487267:A:AT | donor_gain | 0.8200 |
| 21:30487280:T:TA | donor_gain | 0.7800 |
| 21:30487266:C:CT | donor_gain | 0.7400 |
| 21:30487378:G:T | donor_gain | 0.7400 |
| 21:30487382:T:TA | donor_gain | 0.7400 |
| 21:30487214:T:C | donor_gain | 0.7300 |
| 21:30487408:CG:C | donor_gain | 0.7300 |
| 21:30487217:T:TA | donor_gain | 0.7200 |
| 21:30487372:AGCC:A | donor_gain | 0.7000 |
| 21:30487391:G:C | donor_gain | 0.7000 |
| 21:30487300:AG:A | donor_gain | 0.6900 |
| 21:30487350:C:CT | donor_gain | 0.6900 |
| 21:30487301:G:C | donor_gain | 0.6700 |
| 21:30487348:TGCC:T | donor_gain | 0.6700 |
| 21:30487300:AGC:A | donor_gain | 0.6400 |
| 21:30487325:T:TA | donor_gain | 0.6400 |
| 21:30487195:AGAAG:A | donor_gain | 0.6200 |
| 21:30487349:G:A | donor_gain | 0.5900 |
| 21:30487173:A:AC | donor_gain | 0.5800 |
| 21:30487408:CGGT:C | donor_gain | 0.5600 |
| 21:30487401:TAGC:T | donor_loss | 0.5500 |
| 21:30487402:AGCT:A | donor_loss | 0.5500 |
| 21:30487403:GCT:G | donor_loss | 0.5500 |
| 21:30487404:C:CG | donor_loss | 0.5500 |
| 21:30487405:T:TA | donor_loss | 0.5500 |
| 21:30487406:C:CC | donor_loss | 0.5500 |
| 21:30487407:A:AG | donor_loss | 0.5500 |
AlphaMissense
325 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:30487313:G:C | F12L | 0.887 |
| 21:30487313:G:T | F12L | 0.887 |
| 21:30487315:A:G | F12L | 0.887 |
| 21:30487196:G:C | F51L | 0.834 |
| 21:30487196:G:T | F51L | 0.834 |
| 21:30487198:A:G | F51L | 0.834 |
| 21:30487205:G:C | F48L | 0.769 |
| 21:30487205:G:T | F48L | 0.769 |
| 21:30487207:A:G | F48L | 0.769 |
| 21:30487316:G:C | S11R | 0.581 |
| 21:30487316:G:T | S11R | 0.581 |
| 21:30487318:T:G | S11R | 0.581 |
dbSNP variants (sampled 300 via entrez): RS1000108524 (21:30488283 G>T), RS1002414320 (21:30489218 A>T), RS1002904274 (21:30486706 G>A), RS1003856882 (21:30487618 T>C), RS1003909541 (21:30487940 C>A,T), RS1006202742 (21:30488925 A>C), RS1008554 (21:30488255 G>A,C,T), RS1008746558 (21:30488990 G>A), RS1009047981 (21:30487112 C>T), RS1010043400 (21:30488338 C>A,G), RS1013459450 (21:30488524 G>A), RS1013898914 (21:30487981 T>A,C), RS1015829439 (21:30489344 A>G), RS1016387031 (21:30486580 G>A), RS1018070862 (21:30487948 C>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol F | affects cotreatment, decreases methylation | 1 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| butyraldehyde | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Fulvestrant | decreases methylation, affects cotreatment | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.